Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.

Infections of animals with parasitic worms, such as Schistosoma mansoni, induce humoral immune responses to carbohydrate antigens, raising the possibility that such antigens might be useful targets for the development of vaccines and new diagnostic approaches. Here we describe the identification of fucosylated LacdiNAc (LDNF) [GalNAc beta 1-4(Fuc alpha 1-3)GlcNAc-R] as a new carbohydrate antigen in S. mansoni that induces humoral immune responses in infected mice. The presence of antibodies was determined by ELISA using a neoglycoconjugate synthesized to express LDNF sequences. Sera from S. mansoni-infected, but not uninfected, mice contain IgM, IgG, IgA, and IgE antibodies to LDNF. The IgG antibodies are primarily of the IgG1 and IgG3 subclasses, with no detectable levels of the complement-fixing IgG2a and IgG2b isotypes. An IgM monoclonal antibody, designated SMLDNF1, was generated from the spleens of S. mansoni-infected mice, and the antibody exhibits specific recognition of LDNF sequences, but not other fucosylated glycans tested. Immunocytochemical analysis demonstrates that LDNF antigens are localized on the tegumental surface of adult S. mansoni. Western blot analysis indicates that LDNF sequences are expressed on numerous high-molecular-weight glycoproteins from the three major human schistosome species, as well as the bird schistosome Trichobilharzia ocellata. The identification of LDNF antigen on the tegumental glycoproteins of schistosomes and the ability to synthesize LDNF conjugates should aid in the development of glycan-based vaccines and immunodiagnostic tests for schistosomiasis and in determining the role(s) of the glycans in worm development and pathogenesis.

[1]  P. Fallon,et al.  Protection of mice against Schistosoma mansoni infection by passive transfer of sera from infected rabbits , 1996, Parasite immunology.

[2]  S. Do,et al.  α-Lactalbumin Induces Bovine Milk β1,4-Galactosyltransferase to Utilize UDP-GalNAc (*) , 1995, The Journal of Biological Chemistry.

[3]  A. Sher,et al.  Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. , 1999, Journal of immunology.

[4]  D. Dunne,et al.  Passively transferable protection against Schistosoma japonicum induced in the mouse by multiple vaccination with attenuated larvae: the development of immunity, antibody isotype responses and antigen recognition , 1994, Parasite immunology.

[5]  T. Nash,et al.  The characteristics of a circulating antigen in schistosomiasis. , 1974, Journal of immunology.

[6]  R. Corrêa-Oliveira,et al.  Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. , 2000, The American journal of tropical medicine and hygiene.

[7]  P. Fallon,et al.  Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody , 1995, Parasitology.

[8]  A. Simpson,et al.  Analysis of the anti-Schistosoma mansoni surface antibody response during murine infection and its potential contribution to protective immunity. , 1988, Journal of immunology.

[9]  R. Cummings,et al.  Schistosoma mansoni synthesizes novel biantennary Asn-linked oligosaccharides containing terminal beta-linked N-acetylgalactosamine. , 1992, Glycobiology.

[10]  M. Strand,et al.  Schistosoma mansoni, S. haematobium, and S. japonicum: identification of genus- and species-specific antigenic egg glycoproteins. , 1984, Experimental parasitology.

[11]  O. Poulain-Godefroy,et al.  Role of adhesion molecules of the selectin-carbohydrate families in antibody-dependent cell-mediated cytoxicity to schistosome targets. , 1997, Journal of immunology.

[12]  P. Fallon,et al.  Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm , 1997, Parasite immunology.

[13]  R. Wilson,et al.  The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni , 1994, Parasite immunology.

[14]  A. Capron,et al.  Blocking antibodies and vaccine strategy in schistosomiasis. , 1987, Acta tropica. Supplementum.

[15]  P. Das,et al.  IgG4 antibodies in Egyptian patients with schistosomiasis. , 1981, International archives of allergy and applied immunology.

[16]  D. Dunne,et al.  Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. , 1992, Immunological investigations.

[17]  A. Sher,et al.  Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. , 1991, Journal of immunology.

[18]  P. Fallon,et al.  Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. , 1999, Journal of immunology.

[19]  A. Prata,et al.  Evidence for an association between human resistance to Schistosoma mansoni and high anti‐larval IgE levels , 1991, European journal of immunology.

[20]  A. Sher,et al.  Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens. , 1989, Molecular and biochemical parasitology.

[21]  M. Strand,et al.  Identification of antigenic Schistosoma mansoni glycoproteins during the course of infection in mice and humans. , 1985, The American journal of tropical medicine and hygiene.

[22]  R. Cummings,et al.  Binding of Glycosulfopeptides to P-selectin Requires Stereospecific Contributions of Individual Tyrosine Sulfate and Sugar Residues* , 2000, The Journal of Biological Chemistry.

[23]  T. Nash Antibody response to a polysaccharide antigen present in the schistosome gut. I. Sensitivity and specificity. , 1978, The American journal of tropical medicine and hygiene.

[24]  D. H. van den Eijnden,et al.  Novel pathways in complex-type oligosaccharide synthesis: new vistas opened by studies in invertebrates. , 1997, Biochemical Society transactions.

[25]  R. Cummings,et al.  A Novel Glycosulfopeptide Binds to P-selectin and Inhibits Leukocyte Adhesion to P-selectin* , 1999, The Journal of Biological Chemistry.

[26]  R. Cummings,et al.  Core α1→3‐fucose is a common modification of N‐glycans in parasitic helminths and constitutes an important epitope for IgE from Haemonchus contortus infected sheep , 1999, FEBS letters.

[27]  R. Cummings,et al.  Mice infected with Schistosoma mansoni generate antibodies to LacdiNAc (GalNAc beta 1-->4GlcNAc) determinants. , 1999, Glycobiology.

[28]  P. Fallon,et al.  Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel , 1995, Parasite immunology.

[29]  A. Capron,et al.  High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.

[30]  A. Sher,et al.  Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni , 1991, The Journal of experimental medicine.

[31]  A. Satoskar,et al.  Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. , 1999, Journal of immunology.

[32]  R. Cummings,et al.  Rodents infected with Schistosoma mansoni produce cytolytic IgG and IgM antibodies to the Lewis x antigen. , 1997, Glycobiology.

[33]  A. Deelder,et al.  The immunologically reactive part of immunopurified circulating anodic antigen from Schistosoma mansoni is a threonine-linked polysaccharide consisting of --> 6)-(beta-D-GlcpA-(1 --> 3))-beta-D-GalpNAc-(1 --> repeating units. , 1994, The Journal of biological chemistry.

[34]  U. Dräger,et al.  A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Capron,et al.  Immunity in human schistosomiasis mansoni. Regulation of protective immune mechanisms by IgM blocking antibodies , 1986, The Journal of experimental medicine.

[36]  M. Strand,et al.  Schistosoma mansoni, S. haematobium, and S. japonicum: identification of genus-, species-, and gender-specific antigenic worm glycoproteins. , 1984, Experimental parasitology.

[37]  M. Strand,et al.  Schistosoma mansoni: reactivity with infected human sera and monoclonal antibody characterization of a glycoprotein in different developmental stages. , 1982, Experimental parasitology.

[38]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[39]  A. Capron,et al.  Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. , 1989, Journal of immunology.

[40]  K. Khoo,et al.  Structural mapping of the glycans from the egg glycoproteins of Schistosoma mansoni and Schistosoma japonicum: identification of novel core structures and terminal sequences. , 1997, Glycobiology.

[41]  D. Harn,et al.  Lacto-N-fucopentaose III (Lewis x), a target of the antibody response in mice vaccinated with irradiated cercariae of Schistosoma mansoni , 1996, Infection and immunity.

[42]  A. Simpson,et al.  IgM antibodies recognizing carbohydrate epitopes shared between schistosomula and miracidia of Schistosoma mansoni that block in vitro killing. , 1986, Journal of immunology.

[43]  T. Wynn,et al.  Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. , 1999, Journal of immunology.

[44]  A. Simpson,et al.  A major role for carbohydrate epitopes preferentially recognized by chronically infected mice in the determination of Schistosoma mansoni schistosomulum surface antigenicity. , 1986, Journal of immunology.

[45]  G. Gray The direct coupling of oligosaccharides to proteins and derivatized gels. , 1974, Archives of biochemistry and biophysics.

[46]  R. Cummings,et al.  Glycobiology of schistosomiasis , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  K. Khoo,et al.  Structural characterization of glycophingolipids from the eggs of Schistosoma mansoni and Schistosoma japonicum. , 1997, Glycobiology.

[48]  R. Pemberton,et al.  Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine , 1996, Parasitology.

[49]  D. A. Dean,et al.  Homologous and heterologous protective immunity to Egyptian strains of Schistosoma mansoni and S. haematobium induced by ultraviolet‐irradiated cercariae , 1996, Parasite immunology.

[50]  J. Thomas-Oates,et al.  The immunologically reactive O-linked polysaccharide chains derived from circulating cathodic antigen isolated from the human blood fluke Schistosoma mansoni have Lewis x as repeating unit. , 1994, European journal of biochemistry.

[51]  R. Geyer,et al.  Schistosoma mansoni cercarial glycolipids are dominated by Lewis X and pseudo-Lewis Y structures. , 2000, Glycobiology.

[52]  P. Chiodini,et al.  Periodate-sensitive immunological cross-reactivity between keyhole limpet haemocyanin (KLH) and serodiagnostic Schistosoma mansoni egg antigens , 1999, Parasitology.

[53]  K. Khoo,et al.  A Unique Multifucosylated −3GalNAc14GlcNAc13Gal1- Motif Constitutes the Repeating Unit of the Complex O-Glycans Derived from the Cercarial Glycocalyx of Schistosoma mansoni (*) , 1995, The Journal of Biological Chemistry.

[54]  R. Cummings,et al.  Schistosoma mansoniInfection in Humans and Primates Induces Cytolytic Antibodies to Surface LexDeterminants on Myeloid Cells , 1996 .

[55]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[56]  A. Capron,et al.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection , 1992, European journal of immunology.

[57]  A. Simpson,et al.  Human IgE, IgG4 and resistance to reinfection with Schistosomahaematobium , 1991, Nature.

[58]  R. Cummings,et al.  The human blood fluke Schistosoma mansoni synthesizes glycoproteins containing the Lewis X antigen. , 1992, Journal of Biological Chemistry.

[59]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[60]  P Velupillai,et al.  Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Butterworth Immunological aspects of human schistosomiasis. , 1998, British medical bulletin.

[62]  R. Cummings,et al.  Expression of Lex antigen in Schistosoma japonicum and S.haematobium and immune responses to Lex in infected animals: lack of Lex expression in other trematodes and nematodes. , 1998, Glycobiology.

[63]  A. Dessein,et al.  Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area , 1992, European journal of immunology.

[64]  A. Simpson,et al.  Antibody to carbohydrate and polypeptide epitopes on the surface of schistosomula of Schistosoma mansoni in Egyptian patients with acute and chronic schistosomiasis , 1989, Parasitology.